The promising effects of BMP2 transfected mesenchymal stem cells on human osteosarcoma

The promising effects of BMP2 transfected mesenchymal stem cells on human osteosarcoma

Selective concentrating on of transfected mesenchymal stem cells (MSCs) carrying particular antioncogenes to the tumor was recommended as a therapy choice. Bone morphogenetic protein-2 (BMP2) was proven to inhibit the proliferation and aggressiveness of osteosarcoma (OS) cells. Right here, we aimed to evaluate the homing effectivity of intraperitoneally administered hMSCs transfected with BMP2 to the tumoral website…

Read More
BMP2 downregulates urokinase-type plasminogen activator via p38 MAPK: Implications in C2C12 cells myogenic differentiation

BMP2 downregulates urokinase-type plasminogen activator via p38 MAPK: Implications in C2C12 cells myogenic differentiation

Bone morphogenetic protein (BMP)2 strongly impacts the differentiation program of myoblast cells by inhibiting myogenesis and inducing osteogenic differentiation. In flip, extracellular matrix (ECM) proteinases, equivalent to urokinase-type plasminogen activator (uPA), can affect the destiny of muscle stem cells by taking part in ECM reorganization. Though each BMP2 and uPA have antagonistic roles in muscular…

Read More